Clinical Trials Directory

Trials / Completed

CompletedNCT05310110

Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway Insertion Decreasing Propofol in Elderly

The Impact of Using Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway (LMA) Insertion on Hemodynamics and Induction Anesthetics Dosage in Elderly

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Laryngeal mask airway (LMA) is currently the most widely used supraglottic airway device with advantages of simple and fast placement, reduced anesthesia drug use, more stable hemodynamics, and less throat discomfort after anesthesia compared to endotracheal intubation. Some studies claimed the use of muscle relaxants or local anesthetics (sprays or lubricants containing local anesthetics) for the throat before LMA placement can reduce the dosage of induction agents and postoperative throat complications. In modern society, more and more elderly people undergo elective surgery with the need of general anesthesia. However, they are the more vulnerable population with tendency of greater hemodynamic changes with more induction agent usage. Propofol is one of the most used induction agents which may lead to a drop in blood pressure. The objective of this study is to observe whether the dose of propofol and the changes in hemodynamics can be reduced by using muscle relaxants or laryngeal local anesthetics in elderly who receiving general anesthesia with LMA insertion.

Conditions

Interventions

TypeNameDescription
DRUG10% lidocaine spray10% lidocaine spray 3 puff for the throat before induction
DRUGPlacebo of lidocaine sprayNormal saline spray 3 puff for the throat before induction
DRUGCisatracuriumIntravenous cisatracurium 0.12 mg/kg during induction
DRUGPlacebo of cisatracuriumIntravenous normal saline during induction
DRUGPropofolThe dosage of intravenous propofol for the first subjects was predetermined for each arm, and the dosage for the subsequent subjects would be determined according to the response of the previous subjects using the Dixon's up-and-down method with a step size of 0.25 mg/kg. If the subjects had no movement and stable hemodynamic status during and after the laryngeal mask airway (LMA) placement, the predetermined dosage of propofol for the subsequent subject would be decreased by 0.25 mg/kg. On the other hand, if the subjects had obvious movement, failure to LMA placement, and significant hemodynamic changes, the predetermined dosage of propofol for the subsequent subject would be increased by 0.25 mg/kg.

Timeline

Start date
2022-04-12
Primary completion
2023-08-24
Completion
2023-08-24
First posted
2022-04-04
Last updated
2024-02-06

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05310110. Inclusion in this directory is not an endorsement.